JuliaRKoehlerMD
Pediatric Infectious Disease • Boston, MAAssistant Professor of Pediatrics, Boston Children's Hospital
Are you Dr. Koehler?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Ave
Boston, MA 02115Phone+1 617-919-2900Fax+1 617-730-0254
Summary
- Dr. Julia Koehler, MD is a pediatric infectious disease specialist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is an Assistant Professor of Pediatrics at Boston Children's Hospital.
Certifications & Licensure
MA State Medical License 1998 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Infectious Diseases
Publications & Presentations
PubMed
- 11 citationsPlatelet transfusions in a murine model of neonatal polymicrobial sepsis: Divergent effects on inflammation and mortality.Patricia Davenport, Hsuan-Hao Fan, Emily Nolton, Henry A Feldman, Viola Lorenz
Transfusion. 2022-06-01 - 17 citationsGlobal Transcriptomic Analysis of the Candida albicans Response to Treatment with a Novel Inhibitor of Filamentation.Jesus A. Romo, Hao Zhang, Hong Cai, David Kadosh, Julia Koehler
Msphere. 2019-09-11 - 116 citationsExpanding the utility of NMR restraints with paramagnetic compounds: background and practical aspects.Julia Koehler, Jens Meiler
Progress in Nuclear Magnetic Resonance Spectroscopy. 2011-11-01
Press Mentions
- Why Aren’t Daycares Testing Kids for COVID?February 3rd, 2022
- Race Between Boosters, Omicron Plays Out as Cases Surge Across Bay StateDecember 29th, 2021
- Disappointed ‘Beyond Description’: State Sen. Becca Rausch Faults Massachusetts Gov. Charlie Baker on COVID ResponseDecember 21st, 2021
- Join now to see all
Grant Support
- Candida albicans Target of Rapamycin in oxidative stress responsesBOSTON CHILDREN'S HOSPITAL2024–2026
- Candida albicans Target of Rapamycin in oxidative stress responsesBOSTON CHILDREN'S HOSPITAL2024–2026
- Candida albicans Target of Rapamycin in oxidative stress responsesBOSTON CHILDREN'S HOSPITAL2024–2026
- Inhibiting sequential biosynthetic steps of a fungal-specific organelleBOSTON CHILDREN'S HOSPITAL2020–2025
- Compounds that block a novel Candida albicans targetBOSTON CHILDREN'S HOSPITAL2019–2025
